High levels of fumarate or succinate suppress the homologous-recombination DNA-repair pathway in cancer cells that are deficient for FH or SDH, respectively. These tumor cells are vulnerable to PARP inhibitors.
- Parker L. Sulkowski
- Ranjini K. Sundaram
- Peter M. Glazer